Review





Similar Products

variant ctla4 ig fusion proteins cos 7 cells  (ATCC)
99
ATCC variant ctla4 ig fusion proteins cos 7 cells
Variant Ctla4 Ig Fusion Proteins Cos 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/variant ctla4 ig fusion proteins cos 7 cells/product/ATCC
Average 99 stars, based on 1 article reviews
variant ctla4 ig fusion proteins cos 7 cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
mouse recombinant ctla4 ig fusion protein  (Sino Biological)
94
Sino Biological mouse recombinant ctla4 ig fusion protein
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Mouse Recombinant Ctla4 Ig Fusion Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse recombinant ctla4 ig fusion protein/product/Sino Biological
Average 94 stars, based on 1 article reviews
mouse recombinant ctla4 ig fusion protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
abatacept ctla4-ig fusion protein  (Bristol Myers)
90
Bristol Myers abatacept ctla4-ig fusion protein
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Abatacept Ctla4 Ig Fusion Protein, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/abatacept ctla4-ig fusion protein/product/Bristol Myers
Average 90 stars, based on 1 article reviews
abatacept ctla4-ig fusion protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human ctla4-ig fusion protein  (Bristol Myers)
90
Bristol Myers human ctla4-ig fusion protein
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Human Ctla4 Ig Fusion Protein, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ctla4-ig fusion protein/product/Bristol Myers
Average 90 stars, based on 1 article reviews
human ctla4-ig fusion protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ctla4-ig fusion protein abatacept ohrencia  (Bristol Myers)
90
Bristol Myers ctla4-ig fusion protein abatacept ohrencia
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Ctla4 Ig Fusion Protein Abatacept Ohrencia, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla4-ig fusion protein abatacept ohrencia/product/Bristol Myers
Average 90 stars, based on 1 article reviews
ctla4-ig fusion protein abatacept ohrencia - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human ctla4-ig fusion protein  (Bio X Cell)
90
Bio X Cell human ctla4-ig fusion protein
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Human Ctla4 Ig Fusion Protein, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ctla4-ig fusion protein/product/Bio X Cell
Average 90 stars, based on 1 article reviews
human ctla4-ig fusion protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ctla4-ig fusion proteins  (Astellas)
90
Astellas ctla4-ig fusion proteins
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Ctla4 Ig Fusion Proteins, supplied by Astellas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla4-ig fusion proteins/product/Astellas
Average 90 stars, based on 1 article reviews
ctla4-ig fusion proteins - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ssdk ctla4 ig fusion protein fabricator  (Genovis Inc)
97
Genovis Inc ssdk ctla4 ig fusion protein fabricator
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Ssdk Ctla4 Ig Fusion Protein Fabricator, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ssdk ctla4 ig fusion protein fabricator/product/Genovis Inc
Average 97 stars, based on 1 article reviews
ssdk ctla4 ig fusion protein fabricator - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
thtsppspapellg ctla4 ig fusion protein fabricator  (Genovis Inc)
97
Genovis Inc thtsppspapellg ctla4 ig fusion protein fabricator
a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or <t>CTLA4-Ig</t> protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.
Thtsppspapellg Ctla4 Ig Fusion Protein Fabricator, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thtsppspapellg ctla4 ig fusion protein fabricator/product/Genovis Inc
Average 97 stars, based on 1 article reviews
thtsppspapellg ctla4 ig fusion protein fabricator - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or CTLA4-Ig protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.

Journal: Nature Communications

Article Title: Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice

doi: 10.1038/s41467-025-59985-8

Figure Lengend Snippet: a Ligand activities (left, brown), potential receptors (middle, red), and predicted target genes (right, blue) identified by NicheNet analysis based on the key signature genes of transferred OT-II T cells in spleens from WT mice, at day 2.5 post-HDI of pHBV1.3/OVA323-339. Heatmaps showing the absolute expression levels of ligands, receptors, and target genes are also shown. b Representative Violet tracer dilution and proliferation index of OT-II T cells at day 3.5 in the spleens, dLNs, and livers from WT mice treated with anti-Itgb2/LFA1 antibody versus control antibodies, at day 3.5 post-HDI of pHBV1.3/OVA323-339 ( n = 6). c Percentages of dead cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b ) using the viability dye eFluor 780 ( n = 6). d Percentages and number of CXCR5 + Bcl6 hi cells within transferred OT-II T cells in spleens, dLNs, and livers from the mice described in ( b , n = 6). e Same as ( b ), but mice were treated with control or CTLA4-Ig protein ( n = 3). f Same as c , but mice were treated with control or CTLA4-Ig protein ( n = 3). g Same as ( d ), but mice were treated with control or CTLA4-Ig protein ( n = 3). At least two independent experiments were performed. Horizontal lines indicate median values. Statistical significance was calculated using two-tailed Student’s t -tests. Significance levels are indicated as: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Source data and exact p -values are available in the Source Data file.

Article Snippet: For competitive blocking of ALCAM-CD6 and CD80-CD28 pathways, 10 μg/ml mouse recombinant CTLA4-Ig fusion protein (clone CTLA4-Ig, ZXBio) and mouse recombinant CD6 protein (Sino Biological Inc.) were added to the culture medium, respectively.

Techniques: Expressing, Control, Two Tailed Test